Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
The American Journal of Gastroenterology|September 1, 2005
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infectionThierry Poynard, Fabien Zoulim, Vlad Ratziu, et al.
Food Chemistry|September 24, 2013
Differentiation of lemon essential oil based on volatile and non-volatile fractions with various analytical techniques: a metabolomic approachFlorence Mehl, Guillaume Marti, Julien Boccard, et al.
Journal of Hepatology|July 17, 2016
Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCCArnaud Hocquelet, Christophe Aubé, Agnès Rode, et al.
The Journal of Infection|June 7, 2011
Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriersBouchra Kitab, Abdellah Essaid El Feydi, Rajaa Afifi, et al.
Theranostics|October 12, 2020
Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinomaSaravana Kumar Kailasam Mani, Bingyu Yan, Zhibin Cui, et al.
AIDS (London, England)|April 18, 2023
Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIVMaria-Bernarda Requena, Sophie Grabar, Emilie Lanoy, et al.
Liver Cancer|December 17, 2024
Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150Richard S Finn, Peter R Galle, Michel Ducreux, et al.
Plos One|March 24, 2017
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaReetta Holmila, Athena Sklias, David C Muller, et al.
Gastroenterology|March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized studyDidier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2013
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis CDominique Larrey, Ansgar W Lohse, Christian Trepo, et al.
Pageof 20